Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-03-31 Purchase |
2022-04-04 4:27 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
2,500 | $1.9685 | $4,921 | 2,647,969 (Indirect Direct) |
View |
| 2021-12-20 Purchase |
2021-12-22 6:03 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
1,000 | $4.5999 | $4,600 | 2,410,469 (Indirect Direct) |
View |
| 2021-12-15 Purchase |
2021-12-17 8:43 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
750 | $4.7065 | $3,530 | 2,409,469 (Indirect Direct) |
View |
| 2021-12-10 Purchase |
2021-12-14 5:32 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
1,000 | $5.9752 | $5,975 | 2,408,719 (Indirect Direct) |
View |
| 2021-12-02 Purchase |
2021-12-06 5:34 pm |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
1,000 | $6.633 | $6,633 | 2,407,719 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-04-01 Option Award |
2022-04-04 4:27 pm |
N/A 2032-03-31 |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
235,000 | $0 | 2,647,969 (Direct) |
View |
Ownership |
2021-11-01 8:55 pm |
N/A N/A |
Better Therapeutics Inc. | BTTX | Appelbaum Kevin J Kevin Appelbaum or his successor(s) as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020 as amended Chief Executive Officer 10% Owner |
0 | $0 | 2,643,600 (Indirect) |
View |